biote (BTMD) Competitors $3.37 +0.08 (+2.43%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$3.37 0.00 (0.00%) As of 09/11/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BTMD vs. TYRA, GOSS, PROK, DNA, BCAX, SNDL, SEPN, SVRA, MRVI, and ORGOShould you be buying biote stock or one of its competitors? The main competitors of biote include Tyra Biosciences (TYRA), Gossamer Bio (GOSS), ProKidney (PROK), Ginkgo Bioworks (DNA), Bicara Therapeutics (BCAX), SNDL (SNDL), Septerna (SEPN), Savara (SVRA), Maravai LifeSciences (MRVI), and Organogenesis (ORGO). These companies are all part of the "pharmaceutical products" industry. biote vs. Its Competitors Tyra Biosciences Gossamer Bio ProKidney Ginkgo Bioworks Bicara Therapeutics SNDL Septerna Savara Maravai LifeSciences Organogenesis Tyra Biosciences (NASDAQ:TYRA) and biote (NASDAQ:BTMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Which has more risk and volatility, TYRA or BTMD? Tyra Biosciences has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, biote has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Does the media favor TYRA or BTMD? In the previous week, Tyra Biosciences had 6 more articles in the media than biote. MarketBeat recorded 8 mentions for Tyra Biosciences and 2 mentions for biote. biote's average media sentiment score of 1.92 beat Tyra Biosciences' score of 1.22 indicating that biote is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tyra Biosciences 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive biote 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has stronger earnings & valuation, TYRA or BTMD? biote has higher revenue and earnings than Tyra Biosciences. Tyra Biosciences is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTyra BiosciencesN/AN/A-$86.48M-$1.78-7.01biote$197.19M0.84$3.16M$0.903.74 Do analysts rate TYRA or BTMD? Tyra Biosciences presently has a consensus target price of $31.86, suggesting a potential upside of 155.47%. biote has a consensus target price of $6.00, suggesting a potential upside of 78.04%. Given Tyra Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Tyra Biosciences is more favorable than biote.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14biote 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders & institutionals hold more shares of TYRA or BTMD? 84.1% of Tyra Biosciences shares are held by institutional investors. Comparatively, 21.7% of biote shares are held by institutional investors. 15.2% of Tyra Biosciences shares are held by company insiders. Comparatively, 24.0% of biote shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is TYRA or BTMD more profitable? biote has a net margin of 15.73% compared to Tyra Biosciences' net margin of 0.00%. biote's return on equity of -21.00% beat Tyra Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Tyra BiosciencesN/A -31.22% -29.49% biote 15.73%-21.00%18.26% Summarybiote beats Tyra Biosciences on 10 of the 16 factors compared between the two stocks. Get biote News Delivered to You Automatically Sign up to receive the latest news and ratings for BTMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTMD vs. The Competition Export to ExcelMetricbioteMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$162.65M$10.89B$5.78B$10.07BDividend YieldN/A1.85%5.69%4.62%P/E Ratio3.7422.1174.9726.20Price / Sales0.8431.34472.3091.87Price / Cash4.2924.7237.0859.91Price / Book-1.213.5712.116.28Net Income$3.16M$212.34M$3.29B$270.85M7 Day Performance-2.60%-0.03%1.55%3.58%1 Month Performance16.61%4.35%7.83%6.67%1 Year Performance-41.19%-8.77%61.70%27.73% biote Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTMDbiote3.0622 of 5 stars$3.37+2.4%$6.00+78.0%-43.6%$162.65M$197.19M3.74194Positive NewsTYRATyra Biosciences2.4609 of 5 stars$12.13-4.1%$31.43+159.1%-38.7%$674.21MN/A-6.8120Positive NewsAnalyst ForecastGOSSGossamer Bio3.9174 of 5 stars$2.66-9.5%$8.50+219.5%+288.7%$668.50M$114.70M-4.29180Trending NewsAnalyst ForecastOptions VolumeGap UpPROKProKidney3.5584 of 5 stars$2.16-4.0%$6.25+189.4%+24.2%$662.14M$80K-3.793Positive NewsGap UpDNAGinkgo Bioworks1.7668 of 5 stars$11.19+0.3%$9.50-15.1%+67.9%$660.08M$227.04M-1.91640Positive NewsBCAXBicara Therapeutics2.1866 of 5 stars$12.29+1.9%$32.25+162.4%N/A$658.03MN/A-3.8832SNDLSNDL3.764 of 5 stars$2.39-3.6%$4.50+88.3%+15.5%$651.68M$671.81M-8.852,516Positive NewsSEPNSepterna1.8481 of 5 stars$14.67+1.7%$26.75+82.3%N/A$643.36M$1.08M-1.45N/ASVRASavara3.2679 of 5 stars$3.85+3.5%$7.00+81.8%-16.9%$642.95MN/A-7.7020Trending NewsAnalyst ForecastGap UpMRVIMaravai LifeSciences3.5548 of 5 stars$2.44-2.8%$5.22+113.9%-68.3%$640.96M$259.18M-1.79610Positive NewsGap UpORGOOrganogenesis4.033 of 5 stars$4.77-4.6%$7.50+57.2%+96.9%$634.29M$482.04M-34.07950Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Tyra Biosciences Alternatives Gossamer Bio Alternatives ProKidney Alternatives Ginkgo Bioworks Alternatives Bicara Therapeutics Alternatives SNDL Alternatives Septerna Alternatives Savara Alternatives Maravai LifeSciences Alternatives Organogenesis Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTMD) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding biote Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share biote With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTMD Stock Alerts